FOLH1 and neoplasm: For the tracer imaging feasibility study in 10 patients, a high tumor-to-background ratio ranging from 4.7 to 15.3 (average 9.42 ± 2.62 at 2 h after administration, Table 3) for 99mTc-HYNIC-PSMA was observed in malignant lesions.